MedPath

Achieving an empty rectum for prostate radiation therapy: comparison of two laxative treatment.

Phase 4
Completed
Conditions
Prostate cancer
Cancer - Prostate
Registration Number
ACTRN12616000728437
Lead Sponsor
icole Weston
Brief Summary

This study has demonstrated that an osmotic laxative is more effective than a bulking laxative and probiotic at achieving low rectal gas levels during radiation treatment for prostate cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
17
Inclusion Criteria

Adult patients fifty years of age or older undergoing external bean radiotherapy (EBRT) to the intact prostate, using fiducial markers for position verification.

Exclusion Criteria

Severe constipation, abdominal disease (Crohn’s disease, ulcerative colitis, irritable bowel syndrome), history of extensive abdominal surgery, patients using digoxin or salicylates. Individuals whose primary language is other than English.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in rectal volume between the two treatment arms, <br>CT scans are routinely conducted during treatment with a total of 12 collected over the treatment period. Rectal volume will be measured by outlining the prostate, bladder and rectum on all CBCT scans. The rectal volume and cross sectional area will be recorded from this data[Baseline, daily during the first week of treatment and at weekly intervals over a 7 week period while receiving radiation therapy.]; Differences in rectal gas measurements between the two treatment arms, <br>Rectal gas which will be estimated by viewing the CT scan in the mid-sagittal plane and using a semi quantitative scale of 1-5; representing (1)no gas present, (2) gas occupying 5 to less than 25%, (3) 25 t less than 50%, (4) 50 less than 75% and (5) 75 less than 100% of the rectum.[Baseline, daily during the first week of treatment and at weekly intervals over a 7 week period while receiving radiation therapy.]
Secondary Outcome Measures
NameTimeMethod
The number of patients with symptoms of diarrhoea during treatment requiring the cessation of laxatives. This will be assessed at weekly review appointments using the patient self-reported diary which includes the Bristol stool chart.[At baseline and weekly over a 7 week period while receiving radiation therapy]
© Copyright 2025. All Rights Reserved by MedPath